| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-05 15:02:47 UTC |
|---|
| Updated at | 2022-09-05 15:02:47 UTC |
|---|
| NP-MRD ID | NP0215423 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 4-[(1e)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one |
|---|
| Description | Himbacine belongs to the class of organic compounds known as naphthofurans. Naphthofurans are compounds containing a furan ring fused to a naphthalene moiety. Furan is a 5 membered- ring aromatic ring with four carbon and one oxygen atoms. Naphthalene is a polycyclic aromatic hydrocarbon made up of two fused benzene rings. 4-[(1e)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one is found in Galbulimima baccata. 4-[(1e)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one was first documented in 2010 (PMID: 20940295). Based on a literature review a significant number of articles have been published on Himbacine (PMID: 34491059) (PMID: 32691184) (PMID: 29860464) (PMID: 28844401) (PMID: 27366081) (PMID: 26932831). |
|---|
| Structure | CC1OC(=O)C2CC3CCCCC3C(\C=C\C3CCCC(C)N3C)C12 InChI=1S/C22H35NO2/c1-14-7-6-9-17(23(14)3)11-12-19-18-10-5-4-8-16(18)13-20-21(19)15(2)25-22(20)24/h11-12,14-21H,4-10,13H2,1-3H3/b12-11+ |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C22H35NO2 |
|---|
| Average Mass | 345.5270 Da |
|---|
| Monoisotopic Mass | 345.26678 Da |
|---|
| IUPAC Name | 4-[(E)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-dodecahydronaphtho[2,3-c]furan-1-one |
|---|
| Traditional Name | 4-[(E)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3H-naphtho[2,3-c]furan-1-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1OC(=O)C2CC3CCCCC3C(\C=C\C3CCCC(C)N3C)C12 |
|---|
| InChI Identifier | InChI=1S/C22H35NO2/c1-14-7-6-9-17(23(14)3)11-12-19-18-10-5-4-8-16(18)13-20-21(19)15(2)25-22(20)24/h11-12,14-21H,4-10,13H2,1-3H3/b12-11+ |
|---|
| InChI Key | FMPNFDSPHNUFOS-VAWYXSNFSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as naphthofurans. Naphthofurans are compounds containing a furan ring fused to a naphthalene moiety. Furan is a 5 membered- ring aromatic ring with four carbon and one oxygen atoms. Naphthalene is a polycyclic aromatic hydrocarbon made up of two fused benzene rings. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Naphthofurans |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Naphthofurans |
|---|
| Alternative Parents | |
|---|
| Substituents | - Naphthofuran
- Gamma butyrolactone
- Piperidine
- Tetrahydrofuran
- Amino acid or derivatives
- Carboxylic acid ester
- Lactone
- Tertiary amine
- Tertiary aliphatic amine
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Oxacycle
- Azacycle
- Hydrocarbon derivative
- Amine
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Chaudhary NK, Taylor WC, Mander LN, Karuso P: Isolation and Structure Elucidation of Additional Alkaloids from the Tropical Rainforest Tree Galbulimima baccata. J Nat Prod. 2021 Sep 24;84(9):2525-2535. doi: 10.1021/acs.jnatprod.1c00537. Epub 2021 Sep 7. [PubMed:34491059 ]
- Chen Y, Gao F, Zheng G, Gao S: Enantioselective synthesis of a chiral intermediate of himbacine analogs by Burkholderia cepacia lipase A. Biotechnol Lett. 2020 Dec;42(12):2643-2651. doi: 10.1007/s10529-020-02969-z. Epub 2020 Jul 20. [PubMed:32691184 ]
- Carr BJ, Mihara K, Ramachandran R, Saifeddine M, Nathanson NM, Stell WK, Hollenberg MD: Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro. Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2778-2791. doi: 10.1167/iovs.17-22562. [PubMed:29860464 ]
- Sugiyama K, Kawanishi S, Oki Y, Kamiya M, Hanada R, Egi M, Akai S: Lipase-catalyzed asymmetric synthesis of naphtho[2,3-c]furan-1(3H)-one derivatives by a one-pot dynamic kinetic resolution/intramolecular Diels-Alder reaction: Total synthesis of (-)-himbacine. Bioorg Med Chem. 2018 Apr 1;26(7):1378-1386. doi: 10.1016/j.bmc.2017.08.019. Epub 2017 Aug 16. [PubMed:28844401 ]
- Cheng JW: Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxar. Vasc Health Risk Manag. 2016 Jun 14;12:263-8. doi: 10.2147/VHRM.S81342. eCollection 2016. [PubMed:27366081 ]
- Knight E, Robinson E, Smoktunowicz N, Chambers RC, Aliev AE, Inglis GG, Chudasama V, Caddick S: Synthesis of novel and potent vorapaxar analogues. Org Biomol Chem. 2016 Mar 28;14(12):3264-74. doi: 10.1039/c5ob02541a. [PubMed:26932831 ]
- Tantry US, Liu F, Chen G, Gurbel PA: Vorapaxar in the secondary prevention of atherothrombosis. Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1293-305. doi: 10.1586/14779072.2015.1109447. Epub 2015 Nov 12. [PubMed:26559689 ]
- Riddy DM, Valant C, Rueda P, Charman WN, Sexton PM, Summers RJ, Christopoulos A, Langmead CJ: Label-Free Kinetics: Exploiting Functional Hemi-Equilibrium to Derive Rate Constants for Muscarinic Receptor Antagonists. Mol Pharmacol. 2015 Oct;88(4):779-90. doi: 10.1124/mol.115.100545. Epub 2015 Aug 4. [PubMed:26243731 ]
- Authors unspecified: Retraction of "Biomimetic Total Synthesis of Himbacine". Org Lett. 2015 Jun 19;17(12):3190. doi: 10.1021/acs.orglett.5b01596. [PubMed:26087894 ]
- Rivas-Ramirez P, Cadaveira-Mosquera A, Lamas JA, Reboreda A: Muscarinic modulation of TREK currents in mouse sympathetic superior cervical ganglion neurons. Eur J Neurosci. 2015 Jul;42(2):1797-807. doi: 10.1111/ejn.12930. Epub 2015 May 19. [PubMed:25899939 ]
- Diaz-Ricart M, Escolar G: Vorapaxar for the reduction of atherothrombotic events. Drugs Today (Barc). 2014 Nov;50(11):747-56. doi: 10.1358/dot.2014.50.11.2225852. [PubMed:25525635 ]
- Chelliah MV, Eagen K, Guo Z, Chackalamannil S, Xia Y, Tsai H, Greenlee WJ, Ahn HS, Kurowski S, Boykow G, Hsieh Y, Chintala M: Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar. ACS Med Chem Lett. 2014 Mar 11;5(5):561-5. doi: 10.1021/ml500008w. eCollection 2014 May 8. [PubMed:24900880 ]
- Chelliah MV, Chackalamannil S, Xia Y, Greenlee WJ, Ahn HS, Kurowski S, Boykow G, Hsieh Y, Chintala M: Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar. ACS Med Chem Lett. 2013 Dec 18;5(2):183-7. doi: 10.1021/ml400452v. eCollection 2014 Feb 13. [PubMed:24900795 ]
- Chen SR, Chen H, Yuan WX, Wess J, Pan HL: Differential regulation of primary afferent input to spinal cord by muscarinic receptor subtypes delineated using knockout mice. J Biol Chem. 2014 May 16;289(20):14321-30. doi: 10.1074/jbc.M114.550384. Epub 2014 Apr 2. [PubMed:24695732 ]
- Du W, Guo Y, Yuan W: [Role of muscarinic cholinergic receptor subtypes in regulating glutamatergic synaptic transmission in rat spinal dorsal horn]. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Jun;33(6):838-41. [PubMed:23803193 ]
- Chelliah MV, Chackalamannil S, Xia Y, Eagen K, Greenlee WJ, Ahn HS, Agans-Fantuzzi J, Boykow G, Hsieh Y, Bryant M, Chan TM, Chintala M: Discovery of nor-seco himbacine analogs as thrombin receptor antagonists. Bioorg Med Chem Lett. 2012 Apr 1;22(7):2544-9. doi: 10.1016/j.bmcl.2012.01.138. Epub 2012 Feb 16. [PubMed:22405832 ]
- White CW, Short JL, Haynes JM, Matsui M, Ventura S: Contractions of the mouse prostate elicited by acetylcholine are mediated by M(3) muscarinic receptors. J Pharmacol Exp Ther. 2011 Dec;339(3):870-7. doi: 10.1124/jpet.111.186841. Epub 2011 Sep 1. [PubMed:21885618 ]
- Cao XH, Byun HS, Chen SR, Pan HL: Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons. J Neurochem. 2011 Nov;119(3):594-603. doi: 10.1111/j.1471-4159.2011.07456.x. Epub 2011 Sep 21. [PubMed:21883220 ]
- Gonzalez JC, Albinana E, Baldelli P, Garcia AG, Hernandez-Guijo JM: Presynaptic muscarinic receptor subtypes involved in the enhancement of spontaneous GABAergic postsynaptic currents in hippocampal neurons. Eur J Neurosci. 2011 Jan;33(1):69-81. doi: 10.1111/j.1460-9568.2010.07475.x. Epub 2010 Nov 23. [PubMed:21091801 ]
- Chen SR, Chen H, Yuan WX, Wess J, Pan HL: Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice. J Biol Chem. 2010 Dec 24;285(52):40427-37. doi: 10.1074/jbc.M110.176966. Epub 2010 Oct 12. [PubMed:20940295 ]
- LOTUS database [Link]
|
|---|